Report Published: "Belgium Pharmaceuticals & Healthcare Report Q2 2013"
Our forecast sees the Belgian pharmaceutical market contracting over the next three years, only returning to year-on-year (y-o-y) growth in 2015. We have based this view on a combination of patent expirations and the government's focus on cost-containment in the sphere of public spending. Nevertheless, patented medicines will continue to represent the bulk of prescription spending in the country, thus continuing to create commercial opportunities for the manufacturers of novel products.
View full press release